BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vogl TJ, Nour-Eldin NE, Emad-Eldin S, Naguib NN, Trojan J, Ackermann H, Abdelaziz O. Portal vein thrombosis and arterioportal shunts: Effects on tumor response after chemoembolization of hepatocellular carcinoma. World J Gastroenterol 2011; 17(10): 1267-1275 [PMID: 21455325 DOI: 10.3748/wjg.v17.i10.1267]
URL: https://www.wjgnet.com/1007-9327/full/v17/i10/1267.htm
Number Citing Articles
1
Xiao-Hui Zhao, Hang Yuan, Wei-Li Xia, Li-Lin Zhang, Zhen Li, Guang-Shao Cao, Hai-Liang Li, Wei-Jun Fan, Hong-Le Li, Chen-Yang Guo, Quan-Jun Yao, Wen-Bo Zhu, Hong-Tao Hu. Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulasFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.977462
2
Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2013; 12(1): 68 doi: 10.1016/S1499-3872(13)60008-9
3
Mary K. Bryant, David P. Dorn, Jessica Zarzour, J. Kevin Smith, David T. Redden, Souheil Saddekni, Ahmed Kamel Abdel Aal, Stephen H. Gray, Devin E. Eckhoff, Derek A. DuBay. Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolizationHPB 2014; 16(4): 327 doi: 10.1111/hpb.12149
4
Daisuke Yasui, Satoru Murata, Tatsuo Ueda, Fumie Sugihara, Shiro Onozawa, Chiaki Kawamoto, Shinichiro Kumita. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary studyActa Radiologica 2018; 59(3): 266 doi: 10.1177/0284185117717762
5
Junwei Chen, Lisha Lai, Churen Zhou, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombusCancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00581-8
6
Imaging in Gastroenterology2018; : 328 doi: 10.1016/B978-0-323-55408-4.50163-4
7
Yusuke Imai, Masashi Hirooka, Yohei Koizumi, Yoshiko Nakamura, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Eiji Takeshita, Masanori Abe, Hiroaki Tanaka, Mie Kurata, Sohei Kitazawa, Yoichi Hiasa. Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinomaRadiology Case Reports 2017; 12(1): 179 doi: 10.1016/j.radcr.2016.11.006
8
Wei-Li Xia, Xiao-Hui Zhao, Yuan Guo, Hong-Tao Hu, Hai-Liang Li. TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal ShuntsJournal of Hepatocellular Carcinoma 2024; : 1689 doi: 10.2147/JHC.S480082
9
Yuki Nakajima, Atsushi Takahashi, Yukiko Kanno, Naohiko Gunji, Hiromichi Imaizumi, Manabu Hayashi, Ken Okai, Kazumichi Abe, Hiroshi Watanabe, Hiromasa Ohira. Paralytic Ileus due to Superior Mesenteric Venous Thrombosis after Transarterial Injection for Hepatocellular CarcinomaInternal Medicine 2016; 55(1): 37 doi: 10.2169/internalmedicine.55.5907
10
Thierry de Baere, Yasuaki Arai, Riccardo Lencioni, Jean-Francois Geschwind, William Rilling, Riad Salem, Osamu Matsui, Michael C. Soulen. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts OpinionCardioVascular and Interventional Radiology 2016; 39(3): 334 doi: 10.1007/s00270-015-1208-y
11
Ja Kyung Kim, Jun Won Kim, Ik Jae Lee, Seung-Moon Joo, Kwang-Hun Lee, Eun-Suk Cho, Jeong-Sik Yu, Tae Joo Jeon, Yonsoo Kim, Jung Il Lee, Kwan Sik Lee. Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective studyRadiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0873-1
12
Thomas J. Vogl, Patrik Schaefer, Thomas Lehnert, Nour-Eldin A. Nour-Eldin, Hanns Ackermann, Emmanuel Mbalisike, Renate Hammerstingl, Katrin Eichler, Stephan Zangos, Nagy N. N. Naguib. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE)European Radiology 2016; 26(3): 755 doi: 10.1007/s00330-015-3869-y
13
Pin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, Kai-Hsiang Chang, Wei-Chou Chang, Hsuan-Hwai Lin, Cheng-Hsiang Lo, Guo-Shu Huang, Ping-Ying Chang. Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shuntJournal of the Chinese Medical Association 2022; 85(4): 491 doi: 10.1097/JCMA.0000000000000696
14
Ji-Won Kang, Jin Hyoung Kim, Gi-Young Ko, Dong Il Gwon, Hyun-Ki Yoon, Kyu-Bo Sung. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shuntActa Radiologica 2012; 53(5): 545 doi: 10.1258/ar.2012.110476
15
L. Xiao, Q. Liu, W. Zhao, H. Pang, Q. Zeng, Y. Chen, J. Zhao, Q. Mei, X. He. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factorsClinical Radiology 2018; 73(12): 1056.e17 doi: 10.1016/j.crad.2018.08.002
16
Lindsay M. Thornton, Brian S. Geller, Eric W. Pepin, Jehan L. Shah, Melissa Kapp, Beau B. Toskich. Safety of Radioembolization in the Setting of Angiographically Apparent Arterioportal ShuntingJournal of Vascular and Interventional Radiology 2018; 29(11): 1511 doi: 10.1016/j.jvir.2018.06.012
17
Thomas Helmberger. Liver Radioembolization with 90Y MicrospheresMedical Radiology 2013; : 119 doi: 10.1007/174_2013_821
18
Ninggang Zheng, Xiaodong Wei, Dongzhi Zhang, Wenxiao Chai, Ming Che, Jiangye Wang, Binbin Du. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombusMedicine 2016; 95(26): e3959 doi: 10.1097/MD.0000000000003959
19
Junwei Chen, Lisha Lai, Junyang Luo, Haofan Wang, Mingan Li, Mingsheng Huang. DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled studyBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10361-5
20
F. Cauchy, D. Fuks, J. Belghiti. HCC: current surgical treatment conceptsLangenbeck's Archives of Surgery 2012; 397(5): 681 doi: 10.1007/s00423-012-0911-2
21
Yuo-Chen Kuo, Maureen P. Kohi, David M. Naeger, Ricky T. Tong, K. Pallav Kolli, Andrew G. Taylor, Jeanne M. Laberge, Robert K. Kerlan, Nicholas Fidelman. Efficacy of TACE in TIPS Patients: Comparison of Treatment Response to Chemoembolization for Hepatocellular Carcinoma in Patients With and Without a Transjugular Intrahepatic Portosystemic ShuntCardioVascular and Interventional Radiology 2013; 36(5): 1336 doi: 10.1007/s00270-013-0698-8
22
Ahmed Mostafa Mohamed, Mohamed El Gharib A. Elmaaty, Ayman Mohamed Ibrahim, Waleed Hamed, Amr Hafez El Fouly. Diagnosis of arterioportal shunts in cases of hepatocellular carcinoma using multidetector CT: Impact on clinical managementThe Egyptian Journal of Radiology and Nuclear Medicine 2014; 45(1): 25 doi: 10.1016/j.ejrnm.2013.09.011
23
Thomas J. Vogl, Katrin Eichler, Stephan Zangos. Regionale Therapie maligner Tumoren2013; : 237 doi: 10.1007/978-3-642-35014-6_19
24
Michael C. Soulen, Thierry de Baere. Image-Guided Interventions in Oncology2020; : 29 doi: 10.1007/978-3-030-48767-6_3
25
Diagnostic Imaging: Gastrointestinal2015; : 696 doi: 10.1016/B978-0-323-37755-3.50213-0